Siyuan Cui

affiliated hospital of shandong university of traditional chinese medicine

H指数:10

被引数:358

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GPRC5D-directed antibodies in multiple myeloma: new agents and frontline strategies from IMS 2026

GPRC5D靶向抗体在多发性骨髓瘤中的应用：IMS 2026会议上的新药和一线策略

Clinical Lymphoma Myeloma and Leukemia

IF2.7

2026-10-210

PRE

Biomarker implications of gene editing in hematologic diseases: latest updates from ASH 2025

基因编辑在血液疾病中的生物标志物意义：ASH 2025最新更新

Biomarker Research

IF11.5

2026-08-050

Gain/Amplification 17p as a Potential Favorable Prognostic Factor in Multiple Myeloma: A Real-World Settings Retrospective Study

17p增益/扩增作为多发性骨髓瘤中一个潜在的有利预后因素：一项真实世界环境下的回顾性研究

eJHaem

IF0

2025-12-010

OAAI

Advances in Immune Checkpoint Inhibitors for the Treatment of Non-Small-Cell Lung Cancer with Central Nervous System Metastases: A Review

针对中枢神经系统转移的非小细胞肺癌的免疫检查点抑制剂治疗进展：综述

Current Cancer Drug Targets

IF3.5

2025-10-010

PRE

Decoding the AML1/ETO Translocation Cipher: In-depth Exploration into the Pathogenesis and Cutting-edge Therapeutic Strategies of t(8;21) Acute Myeloid Leukemia

解析AML1/ETO易位密码：对t(8;21)急性髓系白血病发病机制及前沿治疗策略的深入探索

critical reviews in oncology hematology

IF0

2025-08-300

PRE

Free fatty acid receptor 4 modulates dietary sugar preference via the gut microbiota

游离脂肪酸受体4通过肠道菌群调节饮食糖偏好

NATURE MICROBIOLOGY

IF19.4

2025-01-132

PRE

Advances in clinical trials on perioperative immune checkpoint inhibitors for resectable non-small cell lung cancer: A comprehensive review

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-11-010

PRE

Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment

CURRENT MEDICINAL CHEMISTRY

IF3.5

2024-09-012

PRE

Research status and prospects of pituitary adenomas in conjunction with neurological and psychiatric disorders and the tumor microenvironment

FRONTIERS IN NEUROSCIENCE

IF3.2

2024-04-220

OAAI

Disease-controlled multiple myeloma in a patient with 17p gain and t(4;14): A case report

HELIYON

IF3.6

2024-04-010

OAAI

Double knockout of FFAR4 and FGF21 aggravates metabolic disorders in mice

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2023-12-010

PRE

Akkermansia muciniphila supplementation improves glucose tolerance in intestinal Ffar4 knockout mice during the daily light to dark transition

MSYSTEMS

IF4.6

2023-10-266

OAAI

Clonal hematopoiesis in unexplained cytopenias

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2023-10-021

OAAI

Zinc Oxide Nanoparticles Trigger Autophagy in the Human Multiple Myeloma Cell Line RPMI8226: an In Vitro Study

氧化锌纳米颗粒在人多发性骨髓瘤细胞系RPMI8226中触发自噬: 一项体外研究

BIOLOGICAL TRACE ELEMENT RESEARCH

IF3.6

2023-07-116

PRE

TERC haploid cell reprogramming: a novel therapeutic strategy for aplastic anemia

MOLECULAR MEDICINE

IF6.4

2023-07-092

OAAI

Genome-wide identification of aberrant alternative splicing and RNA-binding protein regulators in acute myeloid leukaemia which may contribute to immune microenvironment remodelling

CARCINOGENESIS

IF2.9

2023-05-200

PRE

Functions and regulatory mechanisms of resting hematopoietic stem cells: a promising targeted therapeutic strategy

静息态造血干细胞的功能及调控机制: 一种有前景的靶向治疗策略

STEM CELL RESEARCH & THERAPY

IF7.3

2023-04-116

OAAI

The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside

MOLECULES

IF4.6

2022-09-072

OAAI

Brain structural alterations detected by an automatic quantified tool as an indicator for MCI diagnosing in type 2 diabetes mellitus patients: A magnetic resonance imaging study

基于自动量化分析工具检测的脑结构改变作为2型糖尿病患者轻度认知障碍诊断指标：一项磁共振成像研究

HELIYON

IF3.6

2022-05-014

OAAI

Induced effect of zinc oxide nanoparticles on human acute myeloid leukemia cell apoptosis by regulating mitochondrial division

IUBMB LIFE

IF3.2

2022-04-2318

PRE

Siyuan Cui

个人简介

教育背景

工作经历

荣誉奖项

研究方向